| Value | ₹9,513 Cr |
|---|
BSE filing, NSE: IDBI. Summary written from the filing by ALFA Finder's alert engine.
IDBI Bank Ltd: key numbers
- Share price
- ₹80.01
- Market cap
- ₹86,030 Cr
- Revenue (annual)
- ₹29,020 Cr
- Net profit (annual)
- ₹9,210 Cr
- P/E (TTM)
- 10.4×Sector 19.1×
- Promoter holding
- 94.71%+0.00% QoQ
- FII holding
- 0.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from IDBI Bank Ltd
All →IDBI Bank Credit Rating
IDBI Bank's long-term debt was placed on CRISIL AA/Watch Positive; CDs reaffirmed A1+. The watch reflects the proposed Fairfax acquisition of a 60.72% stake.
IDBI Bank Results Update
IDBI Bank released financial highlights for the quarter ended September 30, 2026. The bank reported a net profit of ₹2,205 Crore for the second quarter.
IDBI Bank Q2 FY27 Results: Net Profit ₹2,214 Cr, Down 31.4% YoY
IDBI Bank Ltd reported revenue from operations of ₹8,519 Cr (+19.8% YoY) and net profit of ₹2,214 Cr (-31.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹2,214 Cr · -31.4% YoY
IDBI Bank Other Announcement
IDBI Bank Ltd has filed its quarterly shareholding pattern statement. The report details the distribution of equity shares across various categories of investors.
IDBI Bank Price Movement Clarification
IDBI Bank clarified the news on the government's CABET-approved stake sale to Fairfax. It stated DIPAM leads the competitive disinvestment and the Bank has no role in it.
IDBI Bank Merger & Restructuring Worth ₹52,878 Cr
The Government of India and LIC have sold a 60.72% stake in IDBI Bank to M/s 10955230 Canada Inc. for a total consideration of ₹52,878.08 Crore.
- Value
- ₹52,878 Cr
- From
- M/s 10955230 Canada Inc.
Other financial results announcements
All →Glittek Granites Q2 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr
Glittek Granites Ltd reported revenue from operations of ₹0.3 Cr and net profit of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr
Sudarshan Pharma Industries Q2 FY27 Results: Net Profit ₹8.1 Cr, Up 92.9% YoY
Sudarshan Pharma Industries Ltd reported revenue from operations of ₹217 Cr (+28.5% YoY) and net profit of ₹8.1 Cr (+92.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹8.1 Cr · +92.9% YoY
STL Networks Q2 FY27 Results: Net Loss of ₹16.1 Cr, Loss Narrows
STL Networks Ltd reported revenue from operations of ₹270.1 Cr (+17.0% YoY) and a net loss of ₹16.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹16.1 Cr
RPG Life Sciences Q2 FY27 Results: Net Profit ₹28.2 Cr, Down 23.6% YoY
RPG Life Sciences Ltd reported revenue from operations of ₹211.6 Cr (+16.5% YoY) and net profit of ₹28.2 Cr (-23.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹28.2 Cr · -23.6% YoY
Alldigi Tech Q2 FY27 Results: Net Profit ₹26.6 Cr, Up 51.1% YoY
Alldigi Tech Ltd reported revenue from operations of ₹153.3 Cr (+4.0% YoY) and net profit of ₹26.6 Cr (+51.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹26.6 Cr · +51.1% YoY
Krishna Defence and Allied Industries Q2 FY27 Results: Net Profit ₹1,532 Cr, Up 71.8% YoY
Krishna Defence and Allied Industries Ltd reported revenue from operations of ₹7,529 Cr (+55.7% YoY) and net profit of ₹1,532 Cr (+71.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,532 Cr · +71.8% YoY